Protocadherin-15 (PCDH15 or CDHR15 or USH1F or DFNB23) Antibody

Biological Background

Designed to help you assess Protocadherin-15, this antibody supports studies where protein context matters. Protocadherin-15 is a junctional protein that coordinates adhesion with cytoskeletal anchoring. Its behavior can reflect changes in differentiation state, stress, or remodeling of cellular architecture.

Tracking Protocadherin-15 can clarify whether changes reflect regulation, redistribution, or altered complex assembly.

Use in the Laboratory

In cultured models, junctional readouts can change rapidly after calcium modulation or cytoskeletal perturbation. Because regulation can be multi-layered, combining abundance and localization information can sharpen conclusions. Planar polarity studies may connect this target to directional signaling and cytoskeletal alignment.

Depending on the model, researchers may ask whether signal shifts reflect altered abundance, compartment changes, or remodeling of associated complexes.

To keep datasets interpretable, labs often document:

• subcellular redistribution at contact sites versus cytoplasm
• changes in complex assembly with scaffold or adaptor proteins
• comparative profiling across cell states or perturbations

Version Notes

When assay conditions are still being tuned, a regular-format antibody supports stepwise adjustment of buffers and incubation steps. If your study compares multiple conditions, keep acquisition and processing settings stable to avoid confounding. Small differences in preparation can reshape apparent localization, so interpret results in context.

For challenging targets, pairing Protocadherin-15 measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

As you refine hypotheses around Protocadherin-15, the regular format format helps keep conclusions tied to preparation context.